Ingredients

Alpha Lipoic Acid[study] (ALA): Benefits, Dosage, Evidence & Side Effects (2026)

What Is Alpha Lipoic Acid (ALA)? Alpha lipoic acid is a naturally occurring organosulfur compound produced in small amounts by the human body. It is found in virtually every cell, where it…

What Is Alpha Lipoic Acid (ALA)?

Alpha lipoic acid is a naturally occurring organosulfur compound produced in small amounts by the human body. It is found in virtually every cell, where it plays a role in mitochondrial energy metabolism. Dietary sources include organ meats such as kidney, heart, and liver, as well as spinach, broccoli, Brussels sprouts, and potatoes, though the amounts obtained from food are relatively modest.

As a supplement, ALA is available in synthetic form, typically as a racemic mixture of two mirror-image forms known as R-ALA and S-ALA. The R form is the one produced naturally in the body and is considered more biologically active. ALA is both water- and fat-soluble, a property that distinguishes it from many other antioxidant compounds and allows it to function in a wider range of cellular environments.

How Alpha Lipoic Acid (ALA) Works

ALA functions primarily as a cofactor for mitochondrial enzyme complexes involved in the conversion of nutrients into usable cellular energy (ATP). Beyond its metabolic role, ALA acts as a direct antioxidant, neutralizing reactive oxygen species (free radicals) that can damage cells and tissues.

ALA also contributes to the regeneration of other antioxidants, including vitamins C and E and glutathione, by helping restore them to their active forms after they have neutralized free radicals. This recycling activity is considered one of its more notable biochemical characteristics.

Additionally, research suggests ALA may influence insulin signaling pathways, potentially affecting how cells take up and use glucose. It appears to activate certain cellular pathways, including AMPK (adenosine monophosphate-activated protein kinase), which plays a role in energy balance and metabolic regulation. However, the full extent and clinical relevance of these mechanisms in humans are still being studied.

Evidence & Research

The level of evidence for ALA varies considerably depending on the health outcome in question.

  • Diabetic neuropathy: This is the area with the most robust human clinical data. Multiple randomized controlled trials, particularly using intravenous ALA, have shown statistically significant reductions in neuropathy symptoms such as burning, pain, and numbness. Oral supplementation evidence is more mixed, though some studies suggest benefit. Overall evidence in this area is moderate to moderately strong.
  • Blood sugar regulation: Some clinical trials suggest ALA may modestly improve insulin sensitivity and fasting glucose in people with type 2 diabetes or metabolic syndrome. However, results are inconsistent across studies, and effect sizes are generally small. Evidence is considered mixed.
  • Weight management: A limited number of trials suggest ALA supplementation may contribute to modest reductions in body weight and waist circumference. Evidence in this area is preliminary and not strong enough to draw firm conclusions.
  • Cognitive function: Animal and in vitro studies suggest potential neuroprotective effects. Human clinical evidence remains limited and largely insufficient to support clear conclusions.
  • Cardiovascular markers: Some small studies indicate ALA may reduce oxidative stress markers and modestly influence lipid profiles, but the clinical significance of these findings is unclear. Evidence is preliminary.

It is important to note that many studies have been small in scale, of short duration, or have used varying doses and formulations, which makes direct comparisons difficult.

Typical Dosage

Dosages used in research and seen on supplement labels vary widely. Most human clinical studies have used oral doses ranging from 300 mg to 1,800 mg per day, often divided into two or three doses. A commonly studied range for metabolic or antioxidant purposes is 300 mg to 600 mg daily. For diabetic neuropathy, intravenous doses of 600 mg per day have been used in clinical trials, while oral doses for this purpose have typically ranged from 600 mg to 1,200 mg per day.

Dosage needs and tolerability differ between individuals, and the appropriate amount depends on the intended use, individual health status, and other factors. Consulting a qualified healthcare provider before beginning supplementation is advisable, as optimal dosing has not been definitively established for most applications.

Potential Benefits

  • Research suggests ALA may help reduce symptoms associated with diabetic peripheral neuropathy, particularly burning and pain sensations.
  • Studies indicate it may support modest improvements in insulin sensitivity and blood glucose regulation in certain populations.
  • ALA may contribute to antioxidant defense by neutralizing free radicals and helping regenerate other antioxidants in the body.
  • Preliminary research suggests a possible role in modest body weight reduction when combined with dietary management, though evidence is not conclusive.
  • Some research points to potential neuroprotective properties, though human clinical evidence remains limited.

Side Effects & Safety

ALA is generally considered well tolerated at commonly studied doses, but side effects can occur, particularly at higher doses. Reported adverse effects include nausea, vomiting, stomach upset, headache, and skin rash. Some individuals experience a sensation described as a “pins and needles” feeling, particularly when initiating supplementation.

Because ALA may lower blood glucose levels, there is a risk of hypoglycemia (low blood sugar), especially in individuals already taking diabetes medications or insulin. Blood sugar monitoring may be warranted in these cases.

Very high doses have been associated with more serious effects in isolated reports, and there is limited long-term safety data for doses exceeding those used in clinical trials. Taking ALA on an empty stomach may increase the likelihood of gastrointestinal discomfort.

Who Should Avoid It

  • Pregnant and breastfeeding individuals: Safety data during pregnancy and lactation is insufficient. Use is generally not recommended without medical supervision.
  • People with diabetes or blood sugar disorders: ALA may lower blood glucose and interact with diabetes medications, increasing hypoglycemia risk. Medical oversight is strongly advised.
  • Individuals taking thyroid medications: Some evidence suggests ALA may interfere with thyroid hormone levels or medications such as levothyroxine. Caution and medical consultation are recommended.
  • Those with thiamine (vitamin B1) deficiency: ALA supplementation in the setting of thiamine deficiency may worsen neurological symptoms based on limited preclinical evidence.
  • Individuals on chemotherapy: Due to its antioxidant properties, ALA may theoretically interfere with certain cancer treatments. Consultation with an oncologist is essential before use.
  • Children: Safety and appropriate dosing for pediatric populations have not been adequately established.

Scientific References

Peer-reviewed studies on Alpha Lipoic Acid[study] (ALA) are indexed on PubMed (National Library of Medicine).

Supplements Containing Alpha Lipoic Acid[study] (ALA)

You can find Alpha Lipoic Acid[study] (ALA) in these products we have reviewed:

🕸️ Explore Our Research Web

More Reviews